(Q48127820)

8 February 2018

title

Agmatine inhibits matrix metalloproteinase-9 via endothelial nitric oxide synthase in cerebral endothelial cells. (English)

1 reference

8 February 2018

0 references

Won Taek Lee

6

1 reference

ORCID Public Data File 2021

Kyung Ah Park

5

object named as

Kyung Ah Park

1 reference

8 February 2018

author name string

Mei Zi Yang

1

1 reference

8 February 2018

Chin Hee Mun

2

1 reference

8 February 2018

Yoon Jung Choi

3

1 reference

8 February 2018

Ja Hyun Baik

4

1 reference

8 February 2018

Jong Eun Lee

7

1 reference

8 February 2018

publication date

1 October 2007

1 reference

8 February 2018

published in

Neurological Research

1 reference

8 February 2018

volume

29

1 reference

8 February 2018

issue

7

1 reference

8 February 2018

page(s)

749-754

1 reference

8 February 2018

Agmatine: an endogenous clonidine-displacing substance in the brain

cites work

1 reference

https://api.crossref.org/works/10.1179%2F016164107X208103

The effect of agmatine administration on ischemic-reperfused isolated rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164107X208103

Multiple roles for MMPs and TIMPs in cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164107X208103

Vascular regulation by the L-arginine metabolites, nitric oxide and agmatine

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164107X208103

Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164107X208103

Histochemical characterization of primary capillary endothelial cells from porcine brains using monoclonal antibodies and fluorescein isothiocyanate-labelled lectins: implications for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164107X208103

Agmatine reduces infarct area in a mouse model of transient focal cerebral ischemia and protects cultured neurons from ischemia-like injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164107X208103

Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164107X208103

Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: the phosphatidylinositol 3-kinase/Akt and Raf/ERK pathways transmit opposing signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164107X208103

Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164107X208103

Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164107X208103

The role of nitric oxide and metalloproteinases in the pathogenesis of hyperoxia-induced lung injury in newborn rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164107X208103

Nitric oxide in experimental aneurysm formation: early events and consequences of nitric oxide inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164107X208103

Inhibition of cytokine-induced matrix metalloproteinase 9 expression by peroxisome proliferator-activated receptor alpha agonists is indirect and due to a NO-mediated reduction of mRNA stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164107X208103

21 January 2018

Identifiers

DOI

10.1179/016164107X208103

1 reference

8 February 2018

PubMed ID

17588309

1 reference

8 February 2018